Nicotine

1. 2026-10-19issueIssued info_card
2. 2026-09-24srcNicotine replacement therapy for smoking cessation
3. 2026-09-24srcDifferent doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation.
4. 2026-09-24srcImpact of Prenatal Nicotine Exposure on Placental Function and Respiratory Neural Network Development.
5. 2026-09-24srcNicotine chemistry, metabolism, kinetics and biomarkers.
6. 2026-09-24srcThe neuronal pathways mediating the behavioral and addictive properties of nicotine.
7. 2026-09-24srcHow much nicotine kills a human? Tracing back the generally accepted lethal dose to dubious self-experiments in the nineteenth century.
8. 2026-09-24srcDifferential associations of combined vs. isolated cannabis and nicotine on brain resting state networks.
9. 2026-09-24srcA randomised, open-label, cross-over clinical study to evaluate the pharmacokinetic profiles of cigarettes and e-cigarettes with nicotine salt formulations in US adult smokers.
10. 2026-09-24srcSafety and Efficacy of Monoamine Oxidase Inhibitors in Patients Who Use Psychoactive Substances
11. 2026-09-24srcSmokeless tobacco, sport and the heart.
12. 2026-09-24srcNicotine and the Developing Human: A Neglected Element in the Electronic Cigarette Debate.
13. 2026-09-24srcCardiovascular and Pulmonary Responses to Acute Use of Electronic Nicotine Delivery Systems and Combustible Cigarettes in Long-Term Users.
14. 2026-09-24srcNicotine addiction: More than just dopamine.
15. 2026-09-24srcRelationship between skin melanin index and nicotine pharmacokinetics in African American smokers.
16. 2026-09-24srcAge-dependent effects of tobacco smoke and nicotine on cognition and the brain: A systematic review of the human and animal literature comparing adolescents and adults.
17. 2026-09-24srcA review of monoamine oxidase (MAO) inhibitors in tobacco or tobacco smoke.
18. 2026-09-24srcNicotinic acetylcholine receptors and nicotine addiction: A brief introduction.
19. 2026-09-24srcAcute separate and combined effects of cannabinoid and nicotinic receptor agonists on MMN-indexed auditory deviance detection in healthy humans.
20. 2026-09-24srcMonoamine Oxidase Inhibitors Present in Tobacco Modulate Dopamine Balance Via the Dopamine Transporter.
21. 2026-09-24srcRecent and projected changes in global climate may increase nicotine absorption and the risk of green tobacco sickness.
22. 2026-09-24srcExpression of water-soluble, ligand-binding concatameric extracellular domains of the human neuronal nicotinic receptor alpha4 and beta2 subunits.
23. 2026-09-24srcGreen tobacco sickness: mecamylamine, varenicline, and nicotine vaccine as clinical research tools and potential therapeutics.
24. 2026-09-24srcTobacco use disorder and cardiovascular health.
25. 2026-09-24srcCurrent advances in research in treatment and recovery: Nicotine addiction.
26. 2026-09-24srcHuman Tobacco Smokers in Early Abstinence Have Higher Levels of beta2* Nicotinic Acetylcholine Receptors than Nonsmokers.
27. 2026-09-24srcChronic Nicotine Exposure Alters the Neurophysiology of Habenulo-Interpeduncular Circuitry.
28. 2026-09-24srcNicotinic Acetylcholine Receptors in the Mesolimbic Pathway: Primary Role of Ventral Tegmental Area alpha6beta2* Receptors.
29. 2026-09-24srcA Review of Electronic Cigarettes and Liquid Nicotine Poisoning Exposure Cases in the United States.
30. 2026-09-24srcCognitive Effects of Nicotine: Recent Progress.
31. 2026-09-24srcPhysiologic Functions and Therapeutic Applications of alpha7 Nicotinic Acetylcholine Receptor in Brain Disorders.
32. 2026-09-24srcGlobal Burden of Green Tobacco Sickness in Farm Workers: A Systematic Review and Meta-Analysis.
33. 2026-09-24srcCaffeine, nicotine, cannabis, and psilocybin: Pharmacology, toxicology, and potential therapeutic uses of four naturally occurring psychoactive substances.
34. 2026-09-24srcSubtype-selective up-regulation by chronic nicotine of high-affinity nicotinic receptors in rat brain demonstrated by receptor autoradiography.
35. 2026-09-24srcThe comparative pharmacology and up-regulation of rat neuronal nicotinic receptor subtype binding sites stably expressed in transfected mammalian cells.
36. 2026-09-24srcMetabolism and disposition kinetics of nicotine.
37. 2026-09-24srcCYP2A6 genotype and the metabolism and disposition kinetics of nicotine.
38. 2026-09-24srcPopulation pharmacokinetics of nicotine and its metabolites I. Model development.
39. 2026-09-24srcPsychiatric and psychological features of nicotine dependence.
40. 2026-09-24srcNicotine and sympathetic neurotransmission.
41. 2026-09-24srcAgonist-induced up-regulation of alpha4beta2 nicotinic acetylcholine receptors in M10 cells: pharmacological and spatial definition.
42. 2026-09-24srcNicotine physical properties: CAS 54-11-5, melting point, boiling point, solubility
43. 2026-09-24srcNicotine isolation history: Posselt and Reimann 1828
44. 2026-09-24srcFDA Tobacco Product Standard for Nicotine Yield: Proposed Rule 2025
45. 2026-09-04issueIssued emergency
46. 2026-09-04issueIssued info_card
47. 2026-09-04issueIssued notice
48. 2026-07-03proposaldependence · taper
49. 2026-06-04proposal57 value proposals approved togetherone review action inferred from a shared reviewer and instant — the graph records one activity per proposal
50. 2026-06-04publicationPublication — backfill
51. 2026-04-25revisionRevision 1
52. 2026-04-25genGeneration — pipeline-v5pipeline-v5
53. 2026-04-25rungeneration run
54. 2026-04-25rungeneration run

The same entries, as forms: six forms.